DURECT Shares Outstanding 2006-2020 | DRRX

DURECT shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
DURECT Annual Shares Outstanding
(Millions of Shares)
2019 178
2018 160
2017 145
2016 133
2015 119
2014 112
2013 103
2012 89
2011 87
2010 87
2009 83
2008 78
2007 70
2006 66
2005 54
DURECT Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 202
2020-06-30 207
2020-03-31 196
2019-12-31 178
2019-09-30 192
2019-06-30 164
2019-03-31 162
2018-12-31 160
2018-09-30 162
2018-06-30 162
2018-03-31 154
2017-12-31 145
2017-09-30 152
2017-06-30 143
2017-03-31 142
2016-12-31 133
2016-09-30 138
2016-06-30 133
2016-03-31 122
2015-12-31 119
2015-09-30 120
2015-06-30 119
2015-03-31 114
2014-12-31 112
2014-09-30 112
2014-06-30 111
2014-03-31 110
2013-12-31 103
2013-09-30 102
2013-06-30 102
2013-03-31 102
2012-12-31 89
2012-09-30 88
2012-06-30 88
2012-03-31 88
2011-12-31 87
2011-09-30 87
2011-06-30 87
2011-03-31 87
2010-12-31 87
2010-09-30 87
2010-06-30 87
2010-03-31 87
2009-12-31 83
2009-09-30 83
2009-06-30 82
2009-03-31 82
2008-12-31 78
2008-09-30 82
2008-06-30 75
2008-03-31 74
2007-12-31 70
2007-09-30 70
2007-06-30 69
2007-03-31 69
2006-12-31 66
2006-09-30 69
2006-06-30 64
2006-03-31 62
2005-12-31 54
2005-09-30 53
2005-06-30 52
2005-03-31 52
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.412B $0.030B
Durect Corp. is pioneering the treatment of chronic diseases and conditions by developing and commercializing pharmaceutical systems to deliver the right drug to the right place in the right amount at the right time. Its pharmaceutical systems combine engineering innovations and delivery technology from the medical device and drug delivery industries with its proprietary pharmaceutical and biotechnology drug formulations.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.784B 41.85
Takeda Pharmaceutical (TAK) Japan $54.984B 10.26
Astellas Pharma (ALPMY) Japan $29.565B 18.47
Merck (MKGAF) Germany $22.940B 0.00
Eisai (ESALY) Japan $22.210B 19.35
UCB SA (UCBJF) Belgium $20.583B 0.00
Catalent (CTLT) United States $19.023B 56.90
Grifols, S.A (GRFS) Spain $13.118B 15.02
Neurocrine Biosciences (NBIX) United States $10.061B 79.18
Jazz Pharmaceuticals (JAZZ) Ireland $9.344B 15.10
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.578B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 83.94
Arrowhead Pharmaceuticals (ARWR) United States $8.297B 0.00
United Therapeutics (UTHR) United States $7.680B 16.35
IPSEN SA ADR (IPSEY) France $7.218B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.819B 394.44
Sage Therapeutics (SAGE) United States $4.756B 0.00
PTC Therapeutics (PTCT) United States $4.673B 0.00
Hypermarcas (HYPMY) Brazil $4.415B 17.42
ChemoCentryx (CCXI) United States $4.292B 0.00
FibroGen (FGEN) United States $3.934B 0.00
Cronos Group (CRON) Canada $3.889B 0.00
Corcept Therapeutics (CORT) United States $3.269B 31.62
Pacira BioSciences (PCRX) United States $3.201B 69.51
Nektar Therapeutics (NKTR) United States $3.046B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.972B 15.17
Xencor (XNCR) United States $2.784B 0.00
Revolution Medicines (RVMD) United States $2.706B 0.00
Tilray (TLRY) Canada $2.630B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.766B 15.11
Translate Bio (TBIO) United States $1.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.685B 0.00
USANA Health Sciences (USNA) United States $1.669B 14.69
Endo (ENDP) Ireland $1.640B 2.49
Heron Therapeutics (HRTX) United States $1.603B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.554B 0.00
Ocular Therapeutix (OCUL) United States $1.542B 0.00
Trillium Therapeutics (TRIL) Canada $1.470B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 10.06
ImmunoGen (IMGN) United States $1.404B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.151B 0.00
Indivior (INVVY) United States $1.139B 0.00
Karyopharm Therapeutics (KPTI) United States $1.100B 0.00
Zogenix (ZGNX) United States $1.038B 0.00
ORGANOGENESIS (ORGO) United States $1.024B 0.00
Radius Health (RDUS) United States $1.012B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.938B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.832B 49.10
VAXART, INC (VXRT) United States $0.786B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.721B 0.00
Esperion Therapeutics (ESPR) United States $0.712B 0.00
Acutus Medical (AFIB) United States $0.659B 0.00
Aerie Pharmaceuticals (AERI) United States $0.653B 0.00
Flexion Therapeutics (FLXN) United States $0.644B 0.00
Chinook Therapeutics (KDNY) United States $0.641B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.635B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Harpoon Therapeutics (HARP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.563B 15.80
Molecular Templates (MTEM) United States $0.552B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.524B 0.00
Sundial Growers (SNDL) Canada $0.504B 0.00
PROFOUND MEDICL (PROF) Canada $0.491B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.468B 0.00
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Summit Therapeutics (SMMT) United States $0.438B 0.00
Altimmune (ALT) United States $0.428B 0.00
CASI Pharmaceuticals (CASI) United States $0.420B 0.00
TherapeuticsMD (TXMD) United States $0.414B 0.00
Rafael Holdings (RFL) United States $0.400B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Jounce Therapeutics (JNCE) United States $0.363B 0.00
Concert Pharmaceuticals (CNCE) United States $0.363B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.362B 9.43
Matinas Biopharma Holdings (MTNB) United States $0.327B 0.00
MEI Pharma (MEIP) United States $0.320B 0.00
Alpine Immune Sciences (ALPN) United States $0.313B 0.00
KalVista Pharmaceuticals (KALV) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.304B 19.59
Menlo Therapeutics (VYNE) United States $0.280B 0.00
Lannett Co Inc (LCI) United States $0.279B 7.36
Redhill Biopharma (RDHL) Israel $0.278B 0.00
Jaguar Animal Health (JAGX) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.263B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
Otonomy (OTIC) United States $0.251B 0.00
CTI BioPharma (CTIC) United States $0.245B 0.00
IMV INC (IMV) Canada $0.237B 0.00
Calithera Biosciences (CALA) United States $0.235B 0.00
OptiNose (OPTN) United States $0.218B 0.00
Oncternal Therapeutics (ONCT) United States $0.213B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.209B 0.00
Infinity Pharmaceuticals (INFI) United States $0.204B 0.00
ProPhase Labs (PRPH) United States $0.194B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.188B 0.00
Novan (NOVN) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.179B 0.00
IsoRay (ISR) United States $0.173B 0.00
Onconova Therapeutics (ONTX) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.166B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.165B 0.00
Champions Oncology (CSBR) United States $0.150B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Heat Biologics (HTBX) United States $0.145B 0.00
MediWound (MDWD) Israel $0.137B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.113B 0.00
Lipocine (LPCN) United States $0.106B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.082B 158.75
ElectroCore (ECOR) United States $0.080B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
Recro Pharma (REPH) United States $0.070B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.070B 0.00
AgeX Therapeutics (AGE) United States $0.069B 0.00
Biomerica (BMRA) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
Iterum Therapeutics (ITRM) Ireland $0.059B 0.00
Vical (BBI) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.059B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 24.96
Regulus Therapeutics (RGLS) United States $0.047B 0.00
PolarityTE (PTE) United States $0.042B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.56
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Flex Pharma (SLRX) United States $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 31.90
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00